The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
The U.S. FDA has given the green light for AstraZeneca's FluMist nasal spray vaccine to be self-administered or administered ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
Anyone over 18 will be authorised to administer the vaccine to themselves or another person. Read more at straitstimes.com.
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...